Pricing
  1. US-listed companies
  2. Panbela Therapeutics, Inc.
  3. Financials
  4. Stockholders' equity

Panbela Therapeutics, Inc.【PBLA】

Market cap
$63.36K
P/E ratio
SummaryFinancials
Period EndStockholders' equity (Million USD)YoY (%)
Dec 31, 2023-5-41.25%
Dec 31, 2022-8-178.43%
Dec 31, 202110+20.74%
Dec 31, 20208+509.96%
Dec 31, 20191+416.79%
Dec 31, 20180-107.26%
Dec 31, 2017-4-20.53%
Dec 31, 2016-5+73.14%
Dec 31, 2015-3+1170.86%
Dec 31, 2014-0+52.99%
Dec 31, 2013-0+237.58%
Dec 31, 2012-0

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating expenses Operating income Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSDividend payout ratio (%)Dividend per shareEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)